日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice

[18F] 在学术和社区实践中，滤泡性淋巴瘤患者接受含利妥昔单抗诱导治疗后，正电子发射断层扫描（PET）反应是校正FLIPI评分后生存期的独立预测因子。

期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.1080/10428194.2016.1213824
Wong-Sefidan, Ida; Byrtek, Michelle; Zhou, Xiaolei; Friedberg, Jonathan W; Flowers, Christopher R; Zelenetz, Andrew D; Dawson, Keith L; Reid, Erin
淋巴瘤
发表日期：2017
文献求助 收藏

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma

一项随机开放标签 II 期试验，比较新型 PI3K/哺乳动物雷帕霉素靶蛋白通路抑制剂 Apitolisib (GDC-0980) 与依维莫司治疗转移性肾细胞癌患者的疗效。

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2015.64.8808
Powles, Thomas; Lackner, Mark R; Oudard, Stéphane; Escudier, Bernard; Ralph, Christy; Brown, Janet E; Hawkins, Robert E; Castellano, Daniel; Rini, Brian I; Staehler, Michael D; Ravaud, Alain; Lin, Wei; O'Keeffe, Bridget; Wang, Yulei; Lu, Shan; Spoerke, Jill M; Huw, Ling-Yuh; Byrtek, Michelle; Zhu, Rui; Ware, Joseph A; Motzer, Robert J
肿瘤
肿瘤免疫
信号转导
肾癌
细胞生物学
发表日期：2016
文献求助 收藏

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松治疗后滤泡性淋巴瘤早期复发可识别死亡高风险患者：来自国家淋巴瘤护理研究的分析

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2014.59.7534
Casulo, Carla; Byrtek, Michelle; Dawson, Keith L; Zhou, Xiaolei; Farber, Charles M; Flowers, Christopher R; Hainsworth, John D; Maurer, Matthew J; Cerhan, James R; Link, Brian K; Zelenetz, Andrew D; Friedberg, Jonathan W
淋巴瘤
发表日期：2015
文献求助 收藏

Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States

美国老年滤泡性淋巴瘤的疾病特征、治疗模式、预后、结局和淋巴瘤相关死亡率

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.13399
Nabhan, Chadi; Byrtek, Michelle; Rai, Ashish; Dawson, Keith; Zhou, Xiaolei; Link, Brian K; Friedberg, Jonathan W; Zelenetz, Andrew D; Maurer, Matthew J; Cerhan, James R; Flowers, Christopher R
淋巴瘤
发表日期：2015
文献求助 收藏

The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States

利妥昔单抗维持治疗在美国2004年至2007年间诊断的滤泡性淋巴瘤患者中的应用及疗效

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.28659
Nastoupil, Loretta J; Sinha, Rajni; Byrtek, Michelle; Zhou, Xiaolei; Taylor, Michael D; Friedberg, Jonathan W; Link, Brian K; Cerhan, James R; Dawson, Keith; Flowers, Christopher R
淋巴瘤
发表日期：2014
文献求助 收藏

Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study

一线治疗策略对I期滤泡性淋巴瘤疗效的评估：国家淋巴护理研究分析

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2011.40.6546
Friedberg, Jonathan W; Byrtek, Michelle; Link, Brian K; Flowers, Christopher; Taylor, Michael; Hainsworth, John; Cerhan, James R; Zelenetz, Andrew D; Hirata, Jamie; Miller, Thomas P
淋巴瘤
发表日期：2012
文献求助 收藏